Mervyn D I Vergouwen1, Ewout S Schut, Dirk Troost, Diederik van de Beek. 1. Department of Neurology, H2-259, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.
Abstract
BACKGROUND: There is a widely held belief that cerebral infarction after bacterial meningitis is always caused by vasculitis; however, evidence is weak. We hypothesized that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction in patients with pneumococcal meningitis. METHODS: Sixteen brains of adults who died from pneumococcal meningitis were investigated. Clinical data were collected, and brain sections were scored for signs of inflammation and activation of coagulation. Patients with and without cerebral infarction on autopsy were compared. RESULTS: In total, 38% of patients had focal neurological deficits. Patients died at a median of 7 days (range, 0-32 days) after admission. On autopsy, the nine patients (56%) with cerebral infarctions more often had arterial thrombosis (p = 0.04) than patients without infarction. Patients with infarction tended to have more inflammatory infiltrations of brain parenchyma, microvascular proliferation, small vessel vasculitis/endarteritis obliterans, blood clotting/vessel clogging, and venous thrombosis. None of the patients had large vessel vasculitis. Five patients had cerebral infarctions without vasculitis or endarteritis obliterans. Although four patients with cerebral infarctions had small vessel vasculitis or endarteritis obliterans, areas of infarction could not be localized to the blood flow distribution of these vessels. Blood clotting/vessel clogging was seen in all four patients with vasculitis or endarteritis obliterans, but this was also observed in 10 patients without vasculitis or endarteritis obliterans. None of the patients developed disseminated intravascular coagulation. CONCLUSIONS: Our results suggest that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction complicating pneumococcal meningitis.
BACKGROUND: There is a widely held belief that cerebral infarction after bacterial meningitis is always caused by vasculitis; however, evidence is weak. We hypothesized that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction in patients with pneumococcal meningitis. METHODS: Sixteen brains of adults who died from pneumococcal meningitis were investigated. Clinical data were collected, and brain sections were scored for signs of inflammation and activation of coagulation. Patients with and without cerebral infarction on autopsy were compared. RESULTS: In total, 38% of patients had focal neurological deficits. Patients died at a median of 7 days (range, 0-32 days) after admission. On autopsy, the nine patients (56%) with cerebral infarctions more often had arterial thrombosis (p = 0.04) than patients without infarction. Patients with infarction tended to have more inflammatory infiltrations of brain parenchyma, microvascular proliferation, small vessel vasculitis/endarteritis obliterans, blood clotting/vessel clogging, and venous thrombosis. None of the patients had large vessel vasculitis. Five patients had cerebral infarctions without vasculitis or endarteritis obliterans. Although four patients with cerebral infarctions had small vessel vasculitis or endarteritis obliterans, areas of infarction could not be localized to the blood flow distribution of these vessels. Blood clotting/vessel clogging was seen in all four patients with vasculitis or endarteritis obliterans, but this was also observed in 10 patients without vasculitis or endarteritis obliterans. None of the patients developed disseminated intravascular coagulation. CONCLUSIONS: Our results suggest that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction complicating pneumococcal meningitis.
Authors: Martijn Weisfelt; Rogier M Determann; Jan de Gans; Arie van der Ende; Marcel Levi; Diederik van de Beek; Marcus J Schultz Journal: J Infect Date: 2007-01-04 Impact factor: 6.072
Authors: Martijn Weisfelt; Diederik van de Beek; Lodewijk Spanjaard; Johannes B Reitsma; Jan de Gans Journal: Lancet Neurol Date: 2006-02 Impact factor: 44.182
Authors: D Abramowicz; O Pradier; L De Pauw; P Kinnaert; O Mat; M Surquin; J M Doutrelepont; J L Vanherweghem; P Capel; P Vereerstraeten Journal: Kidney Int Date: 1994-12 Impact factor: 10.612
Authors: Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek Journal: Clin Microbiol Rev Date: 2011-07 Impact factor: 26.132
Authors: Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210
Authors: Bianca Woehrl; Matthijs C Brouwer; Carmen Murr; Sebastiaan G B Heckenberg; Frank Baas; Hans W Pfister; Aeilko H Zwinderman; B Paul Morgan; Scott R Barnum; Arie van der Ende; Uwe Koedel; Diederik van de Beek Journal: J Clin Invest Date: 2011-09-19 Impact factor: 14.808
Authors: Barry B Mook-Kanamori; Daan Fritz; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240